Board Meeting Intimation for Results
Parnax Lab Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 13, 2017, inter alia, to transact the following business.- To consider the proposal of approval of un-audited financial results for the Quarter ended December 31, 2016. Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Parnax Lab Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Standalone & Consolidated Financial Results, Limited Review Report for September 30, 2016
Parnax Lab Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Consolidated Financial Results for the period ended September 30, 20163. Standalone Limited Review for the period ended September 30, 20164. Consolidated Limited Review for the period ended September 30, 2016 Outcome of Board Meeting
Parnax Lab Ltd has informed BSE that in the meeting of the Board of Directors of the Company held on November 14, 2016, inter alia, has transacted the following business:- Consider the proposal of obtaining shareholders approval by postal Ballot Meeting pursuant to Section 110 of Companies Act 2013 read with rule 22 of the companies (Management and Administration) Rules, 2014 and accordingly constitute the postal Ballot Committee by delegating powers to the said committee. Board Meeting on Nov 14, 2016
Parnax Lab Ltd has informed BSE that the meeting of Board of Directors of the Company will be held on November 14, 2016, inter alia, to transact the following business:1. To approve the Unaudited financial results for the quarter ended September 30, 2016;2. To Constitute Postal Ballot Committee and to delegate the powers of Board. Board Meeting Intimation for Results & Closure of Trading Window
Parnax Lab Ltd has informed BSE that the Meeting of the Board of Directors of the Company will be held on November 14, 2016, inter alia, to consider and approve the Companys Standalone and Consolidated Un audited Financial Results for the second quarter ended on September 30, 2016.Further, in terms of the Code of Conduct for Prevention of Insider Trading in Securities of the Company, the Trading Window shall remain closed from October 26,... Shareholding for the Period Ended September 30, 2016
Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Parnax Lab Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Updates on Outcome of AGM
Parnax Lab Ltd has submitted to BSE a copy of Minutes of the 34th Annual General Meeting (AGM) of the Company held on September 28, 2016.